SCHEMBL848119

SCHEMBL848119

CCC(C)(C)c1ccc(C=CC(=O)Nc2cc3ccccc3nc2Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.45
TNIK Q9UKE5 1/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOB P27338 1/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MMP1 P03956 2/20 0.41
MMP2 P08253 2/20 0.41
MMP9 P14780 2/20 0.41
HCAR2 Q8TDS4 1/20 0.41
EGFR P00533 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL848118 1.00 TRPV1 (0.45) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL847086 0.89 TRPV1 (0.56) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL847085 0.89 TRPV1 (0.56) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL846559 0.80 TRPV1 (0.54) TRPV1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL846558 0.80 TRPV1 (0.54) TRPV1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL846919 0.79 RAB9A (0.44) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL846918 0.79 RAB9A (0.44) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL12719786 0.77 TRPV1 (0.56) TRPV1TNIKNPC1RAB9ALMNA
SCHEMBL846183 0.76 MAPT (0.58) NPC1RAB9ALMNASMN1; SMN2MAPT
SCHEMBL846184 0.76 MAPT (0.58) NPC1RAB9ALMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP disclosed
EP-2308848-A1 Quinoline-derived amide modulators of vanilloid VR1 receptor Janssen Pharmaceutica NV (BE) 2011-04-13 EP disclosed